Bephar SA
Bephar reported total assets of 466,425 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Bephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -55 % Total assets +26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bephar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
Bephar's financial analysis
- Solvency35.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bephar
Bephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0450.260.538
- VAT number
- BE0450260538
- Peppol
- Registered · 0208:0450260538 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Jun 1993
- Registered office
- 7080 Frameries
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bephar (SA) has been based in Frameries since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 32,036 € and equity of 165,161 €; its revenue is not published. Its solvency stands at 35.4%, below the median of its sector (41.5%).
Companies similar to Bephar
Companies in the same business, of comparable size and area, outside its group.
- MV Pharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 469,186 €
- Vancophar Retail sale of pharmaceutical products Bierbeek · balance sheet 466,628 €
- Apotheek Poelk Retail sale of pharmaceutical products Ninove · balance sheet 466,202 €
- Pharmacie DE LA Chasse Retail sale of pharmaceutical products Etterbeek · balance sheet 467,044 €
- Vipharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 467,095 €
- Frencken Retail sale of pharmaceutical products Antwerp · balance sheet 464,818 €
- PharmaConseil Retail sale of pharmaceutical products Verviers · balance sheet 468,687 €
- Jely Pharma Retail sale of pharmaceutical products Incourt · balance sheet 469,684 €
Frequently asked questions about Bephar
What is the revenue of Bephar?
Bephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bephar?
In Belgium, the VAT number is the company number prefixed with BE: BE0450260538 for Bephar, if the company is VAT-registered. Its company number (CBE) is 0450.260.538.
Where is the registered office of Bephar?
According to the CBE register, the registered office of Bephar is in 7080 Frameries.
What is the equity of Bephar?
At the close of the 2025 financial year, the equity of Bephar amounts to 165,161 €, a solvency of 35.4% of total assets.
Who manages Bephar?
The register lists 6 active mandates at Bephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →